Stock EXAS EXACT SCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Exact Sciences Corporation

Equities

EXAS

US30063P1057

Real-time Estimate Cboe BZX
Other stock markets
 17:09:57 10/05/2024 BST 		5-day change 1st Jan Change
52.87 USD -2.36% Intraday chart for Exact Sciences Corporation -14.90% -28.60%
05-08 Exact Sciences Q1 Net Loss Widens, Revenue Increases; 2024 Revenue Outlook Maintained -- Shares Fall After Hours MT
05-08 Transcript : Exact Sciences Corporation, Q1 2024 Earnings Call, May 08, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exact Sciences: Q1 Earnings Snapshot
AQ
Exact Sciences Announces First-Quarter 2024 Results
BU
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
BU
Exact Sciences : ESG Report for the FY ended 12/31/2023
PU
Exact Sciences : SASB Index for the FY ended 12/30/2023
PU
Exact Sciences : TCFD Report for the FY ended 12/29/2023
PU
Exact Sciences to Participate in May Investor Conference
BU
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
BU
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
BU
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
BU
Exact Sciences Schedules First Quarter 2024 Earnings Call
BU
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
BU
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
AQ
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
BU
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
BU
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
BU
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
BU
EXACT SCIENCES LAUNCHES RISKGUARD HEREDITARY CANCER TEST IN THE UNITED STATES
AQ
Exact Sciences to Participate in March Investor Conference
BU
Exact Sciences: Q4 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXAS Stock
  4. News Exact Sciences Corporation
  5. Press Releases